Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > 1.2 M in cash....anyone know how far that will go :)
View:
Post by DJDawg on Jun 30, 2023 4:38pm

1.2 M in cash....anyone know how far that will go :)


Comment by Yajne on Jun 30, 2023 4:42pm
Many months back, I had estimated their burn rate to be ~$300K/mo Not sure if that's still the case.
Comment by skys1 on Jun 30, 2023 5:03pm
This should get them to BTD approval, then they will be far more appealing to the big pharma crowd. Much can happen then, especially with their new BOD member that has much experience working that crowd.
Comment by StevenBirch on Jun 30, 2023 7:51pm
Size does matter evidently, each PP has gotten smaller like they are doing the bare minimum to get to the next threshold. They can't control the time that it's taking and per Jaro from the AGM they will take no shortcuts but $1.2M? We MUST be getting close. 
Comment by Jaro1977 on Jun 30, 2023 8:21pm
funny story, as soon as the questions period opened up, a gentleman with what appeared to be his grandson asked "how is our cash position?"  To which Roger replied, "why, you wanna give me some?"  The gentleman replied "see me afterwards".  Total speculation here but might he be the non-brokered private placement?  Again, just speculation.  ...more  
Comment by Jaro1977 on Jun 30, 2023 8:22pm
I expect about 1-1.2 years, enough to bet BTD advance GLP studies
Comment by ScienceFirst on Jul 01, 2023 9:45am
This This low pp is a bridge pp to the FDA Breakthrough's response.  No doubt. TLT is doing the right things, in the right order, at the right moment.  Up to big pharmas to confirm their interest.   Highest efficacy % translate into larger market shares for the one that will want to jv with us. Very interesting to see Dr. Kamat presenting our treatment @AUA on p. 11 of ...more  
Comment by Oilminerdeluxe on Jun 30, 2023 4:42pm
Enough to get us to BTD land, and then another raise at higher prices? 
Comment by riverrrow on Jun 30, 2023 9:03pm
Well, we certainly can't complain about share dilution with this pp.  Is it illegal or something for Merck or another pharma to participate in a pp?
Comment by skys1 on Jul 01, 2023 9:53am
riverrow,  yes they can, and they don't have to report anything publically until their shares reach 10%.
Comment by Oilminerdeluxe on Jul 01, 2023 10:00am
Happy to see money in the bank. It will last a while at least. Now bring on the BTD please and whatever will come after that. 
Comment by Legit62 on Jul 04, 2023 7:31am
I think we pulled in 1.477 million in that round plus what we had in kitty, probably bring us to early 2024 , but like Skys said, small for a reason, probably have something in the works and didnt need a big PP IMO. US side closed today, maybe some news within a few weeks
Comment by BlueFranky on Jun 30, 2023 4:59pm
Enough to get us to the next benchmark and a raising at a buck a share? ;-)
Comment by N0taP00p on Jun 30, 2023 10:05pm
@DJDawg:  Much less than a year if they really intend to use it for for other indications.  All I see at this point after all the hoopla over poster presentations, the return of the saviour,  youtube interviews that get  staggering views in the hundreds (someone check, could be a thousand),  data to drool over...and yet we can only raise money at a princely 25 cents, that ...more  
Comment by Sunvalley on Jun 30, 2023 10:48pm
Fine with me nincompoop ! .  Enjoy your stay at the institute. Hope the treatments are successful. Not!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250